Trials / Completed
CompletedNCT01253499
Multiple Dose Study of TRx0037
A Phase 1 Study Consisting of a Double-Blind, Placebo Controlled Multiple Dose Study of TRx0037 in Healthy Elderly Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- TauRx Therapeutics Ltd · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of TRx0037 after multiple doses in elderly volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRx0037 | 75mg and 100mg tablets used to create doses of 100mg and 175mg. Active placebo 2mg and blank placebo used as comparators. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2010-12-03
- Last updated
- 2010-12-17
Source: ClinicalTrials.gov record NCT01253499. Inclusion in this directory is not an endorsement.